SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-032269
Filing Date
2024-08-14
Accepted
2024-08-14 16:31:04
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 873718
2 ex10-1.htm EX-10.1 107338
3 ex31-1.htm EX-31.1 17635
4 ex31-2.htm EX-31.2 17915
5 ex32-1.htm EX-32.1 8364
  Complete submission text file 0001493152-24-032269.txt   4600703

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ntbl-20240630.xsd EX-101.SCH 39300
7 XBRL CALCULATION FILE ntbl-20240630_cal.xml EX-101.CAL 53466
8 XBRL DEFINITION FILE ntbl-20240630_def.xml EX-101.DEF 118617
9 XBRL LABEL FILE ntbl-20240630_lab.xml EX-101.LAB 312858
10 XBRL PRESENTATION FILE ntbl-20240630_pre.xml EX-101.PRE 243553
71 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 577794
Mailing Address 320 HATCH DRIVE FOSTER CITY CA 94404
Business Address 320 HATCH DRIVE FOSTER CITY CA 94404 415-851-2410
Notable Labs, Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36581 | Film No.: 241208629
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)